PMID: 37259Apr 1, 1979

A comparison of self-delivered consequences and desensitization in the treatment of fear of rats

Journal of Clinical Psychology
A M Gross, T A Brigham

Abstract

Exposed 52 rat phobic Ss to either group desensitization, self-delivered consequences imagined exposure, self-delivered consequences in-vivo exposure, or no treatment. Self-delivered consequences Ss conducted the treatment on their own and self-delivered preselected reinforcers contingent upon performance of the treatment exercises. All treatment groups improved significantly more than the no-treatment control group. The self-delivered consequences imagined exposure and the group desensitization treatments were equally effective. The self-delivered consequences in-vivo exposure treatment was significantly more effective than the self-delivered consequences imagined exposure and group desensitization treatments. The applicability of self-management techniques to the treatment of fear responses to specific stimuli and an extinction explanation of the effectiveness of systematic desensitization are discussed.

References

Jan 1, 1985·Behaviour Research and Therapy·R B Levin, A M Gross
Sep 11, 2013·The Cochrane Database of Systematic Reviews·Evan Mayo-Wilson, Paul Montgomery

Citations

Nov 1, 1973·Behaviour Research and Therapy·M Hamilton, H E Schroeder
May 1, 1972·Behaviour Research and Therapy·D Sue
Oct 1, 1968·Journal of Consulting and Clinical Psychology·L P Rehm, A R Marston

Related Concepts

Phobia, Social
Behavior Therapy
Psychological Desensitization Therapy

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.